DJIA 16,328.94 66.38 0.41%
NASDAQ 4,046.42 12.26 0.30%
S&P 500 1,850.03 7.05 0.38%
market minute promo

6.82 0.13 (1.94%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ARIA $6.82 1.94%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.74
Previous Close $6.69
Daily Range $6.66 - $6.85
52-Week Range $2.15 - $23.00
Market Cap $1.3B
P/E Ratio -4.49
Dividend (Yield) $0.00 (0.0%)
Volume 2,216,513
Average Daily Volume 12,244,357
Current FY EPS -$1.03

Sector

Healthcare

Industry

Drugs

Ariad Pharmaceuticals, Inc. (ARIA) Description

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules. Website: http://www.ariad.com/

News & Commentary Rss Feed

ARIAD Pharmaceuticals, Inc. Battling Back

Since returning to market, ARIAD Pharmaceuticals has captured about half of the patients on Iclusig before it went off the market, but it'll have a hard time competing with Novartis' and Bristol-Myers Squibb's leukemia drugs.

ARIAD Pharmaceuticals Inc (ARIA): Today's Featured Health Care Laggard

FDA Approves Novartis' ALK Inhibitor! Maybe...Really Soon?

Sarah Ketterer of Causeway Capital's Answers to GuruFocus Q&A

Causeway Capital's Sarah Ketterer Responds to GuruFocus Reader Questions

Market Wrap For March 28: Markets Still Positive Despite Giving Up Early Gains

Healthcare Stocks Falling Back to Near Even; Ariad Pharma Rises After Starting New Testing of Cancer

Healthcare Stocks Falling Back to Near Even; Ariad Pharma Rises After Starting New Testing of Cancer Drug

Sector Update: Healthcare

Mid-Day Market Update: Restoration Hardware Surges On Earnings; Endocyte Shares Drop

ARIAD Candidate in Phase II Study - Analyst Blog

Novartis Targeted Lung Cancer Drug Highlighted in This Week's NEJM

See More ARIA News...

ARIA's Top Competitors

ARIA $6.82 (1.94%)
Current stock: ARIA
AMGN $115.21 (0.18%)
Current stock: AMGN
GILD $69.21 (1.53%)
Current stock: GILD
BIIB $290.00 (1.58%)
Current stock: BIIB